Synaptic AMPA receptor subunit trafficking is independent of the C terminus in the GluR2-lacking mouse

por Panicker, Sandip, Brown, Keith, Nicoll, Roger A.
Publicado 2008

Classical Complement Pathway Activation in ITP: Inhibition by a novel C1s inhibitor

por Peerschke, Ellinor I. B., Panicker, Sandip, Bussel, James
Publicado en Br J Haematol (2015)

Evidence for a Centrally Located Gate in the Pore of a Serotonin-Gated Ion Channel

por Panicker, Sandip, Cruz, Hans, Arrabit, Christine, Slesinger, Paul A.
Publicado en J Neurosci (2002)

Uncoupling complement C1s activation from C1q binding in apoptotic cell phagocytosis and immunosuppressive capacity

por Colonna, Lucrezia, Parry, Graham C., Panicker, Sandip, Elkon, Keith B.
Publicado en Clin Immunol (2016)

C1s Inhibition by BIVV009 (Sutimlimab) Prevents Complement-Enhanced Activation of Autoimmune Human B Cells In Vitro

por Nikitin, Pavel A., Rose, Eileen L., Byun, Tony S., Parry, Graham C., Panicker, Sandip
Publicado en J Immunol (2019)

Complement-Mediated Enhancement of Monocyte Adhesion to Endothelial Cells by HLA Antibodies, and Blockade by a Specific Inhibitor of the Classical Complement Cascade, TNT003

por Valenzuela, Nicole M., Thomas, Kimberly A., Mulder, Arend, Parry, Graham C., Panicker, Sandip, Reed, Elaine F.
Publicado en Transplantation (2017)

Real-Time Imaging of Discrete Exocytic Events Mediating Surface Delivery of AMPA Receptors

por Yudowski, Guillermo A., Puthenveedu, Manojkumar A., Leonoudakis, Dmitri, Panicker, Sandip, Thorn, Kurt S., Beattie, Eric C., von Zastrow, Mark
Publicado 2007

A Randomized, First‐in‐Human, Healthy Volunteer Trial of sutimlimab, a Humanized Antibody for the Specific Inhibition of the Classical Complement Pathway

por Bartko, Johann, Schoergenhofer, Christian, Schwameis, Michael, Firbas, Christa, Beliveau, Martin, Chang, Colin, Marier, Jean‐Francois, Nix, Darrell, Gilbert, James C., Panicker, Sandip, Jilma, Bernd
Publicado en Clin Pharmacol Ther (2018)

Blockade of HLA Antibody-Triggered Classical Complement Activation in Sera From Subjects Dosed With the Anti-C1s Monoclonal Antibody TNT009—Results from a Randomized First-in-Human...

por Mühlbacher, Jakob, Jilma, Bernd, Wahrmann, Markus, Bartko, Johann, Eskandary, Farsad, Schörgenhofer, Christian, Schwameis, Michael, Parry, Graham C., Gilbert, James C., Panicker, Sandip, Böhmig, Georg A.
Publicado en Transplantation (2017)

AF-353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist

por Gever, Joel R, Soto, Rothschild, Henningsen, Robert A, Martin, Renee S, Hackos, David H, Panicker, Sandip, Rubas, Werner, Oglesby, Ian B, Dillon, Michael P, Milla, Marcos E, Burnstock, Geoffrey, Ford, Anthony PDW
Publicado 2010

Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial

por Jäger, Ulrich, D’Sa, Shirley, Schörgenhofer, Christian, Bartko, Johann, Derhaschnig, Ulla, Sillaber, Christian, Jilma-Stohlawetz, Petra, Fillitz, Michael, Schenk, Thomas, Patou, Gary, Panicker, Sandip, Parry, Graham C., Gilbert, James C., Jilma, Bernd
Publicado en Blood (2019)